𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of minimal residual disease in acute myeloid leukemia

✍ Scribed by Maria R. Baer

Book ID
107546145
Publisher
Current Science Inc.
Year
2002
Tongue
English
Weight
236 KB
Volume
4
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The use of receiver operating characteri
The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse
✍ Adhra Al-Mawali; David Gillis; Ian Lewis πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 461 KB πŸ‘ 2 views

## Abstract ## Background: Multiparameter flow cytometry (MFC) has been shown to be a useful approach for detection of minimal residual disease (MRD). The aim of the study was to determine the optimal threshold that can separate patients into two groups in terms of leukemic residual cells and rela

Monitoring of minimal residual disease i
Monitoring of minimal residual disease in acute myeloid leukemia
✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo

Detection of minimal residual disease in
Detection of minimal residual disease in acute leukemia by flow cytometry
✍ Dario Campana; Elaine Coustan-Smith πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

Patients with acute leukemia in clinical remission may still have up to 10 10 residual malignant cells (the upper limit of detection by standard morphologic techniques). Sensitive techniques to detect minimal residual disease (MRD) may allow better estimates of the leukemia burden and help the selec